Predicting the cause of temporary double vision
Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Diplopia
Fondation Ophtalmologique Adolphe de Rothschild · NCT02576925
This study is trying to create a scoring system to help doctors figure out the urgent causes of temporary double vision that lasts less than a day.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 220 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild (network) |
| Locations | 2 sites (Paris and 1 other locations) |
| Trial ID | NCT02576925 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a clinical score to help clinicians identify the ischemic etiology of transient diplopia, which is defined as double vision lasting less than 24 hours. By conducting thorough clinical, ophthalmological, and neurological evaluations, the study seeks to differentiate between various causes of transient diplopia, particularly focusing on those that require urgent care. The goal is to enhance diagnostic accuracy and improve patient management in cases of transient diplopia.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have experienced transient diplopia lasting less than 24 hours within the past 8 days.
Not a fit: Patients with permanent or non-transient diplopia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to quicker and more accurate diagnoses for patients experiencing transient diplopia, potentially improving outcomes in cases of ischemic origin.
How similar studies have performed: While the approach of developing a predictive score for transient diplopia is innovative, similar studies focusing on diagnostic scoring systems in ophthalmology have shown promise in improving clinical outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Transient diplopia (i.e. less than 24 hours) during the last 8 days Exclusion Criteria: \-
Where this trial is running
Paris and 1 other locations
- Hôpital Bichat — Paris, France (RECRUITING)
- Fondation Ophtalmologique Adolphe de Rothschild — Paris, Île-de-France Region, France (RECRUITING)
Study contacts
- Study coordinator: Michel Rosenheim, MD, DSc
- Email: mrosenheim@fo-rothschild.fr
- Phone: +33148036457
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diplopia